Medicine Man Technologies, Inc.
SHWZ · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $43 | $42 | $43 | $47 |
| % Growth | 3.9% | -4% | -7.3% | – |
| Cost of Goods Sold | $24 | $24 | $45 | $25 |
| Gross Profit | $19 | $18 | -$2 | $21 |
| % Margin | 44% | 43.1% | -4.9% | 45.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $2 | $21 | $13 |
| SG&A Expenses | $22 | $21 | $12 | $13 |
| Sales & Mktg Exp. | $21 | $19 | -$9 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $22 | $21 | $12 | $13 |
| Operating Income | -$3 | -$3 | -$16 | $9 |
| % Margin | -6.3% | -6.5% | -37.5% | 19.1% |
| Other Income/Exp. Net | -$7 | -$9 | -$9 | -$4 |
| Pre-Tax Income | -$10 | -$12 | -$25 | $5 |
| Tax Expense | $4 | $4 | $4 | $5 |
| Net Income | -$14 | -$16 | -$29 | -$0 |
| % Margin | -32.2% | -38.6% | -67.8% | -0.7% |
| EPS | -0.2 | -0.24 | -0.44 | -0.004 |
| % Growth | 16.7% | 45.5% | -11,791.9% | – |
| EPS Diluted | -0.2 | -0.24 | -0.44 | -0.004 |
| Weighted Avg Shares Out | 79 | 76 | 72 | 87 |
| Weighted Avg Shares Out Dil | 79 | 76 | 72 | 87 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8 | $8 | $8 | $8 |
| Depreciation & Amortization | $7 | $5 | $5 | $7 |
| EBITDA | $4 | $2 | -$12 | $21 |
| % Margin | 9.8% | 5.7% | -28.2% | 44.4% |